@article{ca455c4fa682429cbd0396248ce53e56,
title = "The State of Diabetes Prevention Policy in the USA Following the Affordable Care Act",
abstract = "Type 2 diabetes is a major public health problem in the USA, affecting over 12 % of American adults and imposing considerable health and economic burden on individuals and society. There is a strong evidence base demonstrating that lifestyle behavioral changes and some medications can prevent or delay the onset of type 2 diabetes in high risk adults, and several policy and healthcare system changes motivated by the Patient Protection and Affordable Care Act (ACA) have the potential to accelerate diabetes prevention. In this narrative review, we (1) offer a conceptual framework for organizing how the ACA may influence diabetes prevention efforts at the level of individuals, healthcare providers, and health systems; (2) highlight ACA provisions at each of these levels that could accelerate type 2 diabetes prevention nationwide; and (3) explore possible policy gaps and opportunity areas for future research and action.",
keywords = "Affordable Care Act, Diabetes, Health policy, Prediabetes, Primary prevention",
author = "Konchak, {Juleigh Nowinski} and Moran, {Margaret R.} and O{\textquoteright}Brien, {Matthew J.} and Kandula, {Namratha R.} and Ackermann, {Ronald T.}",
note = "Funding Information: The authors acknowledge support from National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (K23 DK095981, O{\textquoteright}Brien), and National Center for Advancing Translational Sciences (UL1 TR001422, Ackermann). Funding Information: Namratha Kandula discloses that she receives salary support from the American Medical Association and honoraria from Patient-Centered Outcomes Research Institute for serving as a grant reviewer. Juleigh Nowinski Konchak, Margaret Moran, Matthew O{\textquoteright}Brien, and Ronald Ackermann declare that they have nothing to disclose. Funding Information: The authors acknowledge support from National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (K23 DK095981, O'Brien), and National Center for Advancing Translational Sciences (UL1 TR001422, Ackermann). Namratha Kandula discloses that she receives salary support from the American Medical Association and honoraria from Patient-Centered Outcomes Research Institute for serving as a grant reviewer. Juleigh Nowinski Konchak, Margaret Moran, Matthew O'Brien, and Ronald Ackermann declare that they have nothing to disclose. Publisher Copyright: {\textcopyright} 2016, Springer Science+Business Media New York.",
year = "2016",
month = jun,
day = "1",
doi = "10.1007/s11892-016-0742-6",
language = "English (US)",
volume = "16",
journal = "Current Diabetes Reports",
issn = "1534-4827",
publisher = "Current Medicine Group",
number = "6",
}
